Clinical Research Service
Phase II-IV Clinical Trials
- over 300 Phase II and III studies completed
- 35-40 new studies initiated/year
- more than 5000 subjects enrolled
- 6 regulatory inspection by Hungarian Regulatory Authority (2009, 2015, 2018, 2021, 2022)
- 2 FDA inspection with NAI (No Action Indicated) results in 2017 and 2018
- over 50 sponsor and CRO audits successfully completed
- currently worldwide top enroller in many studies in different indications
- patient retention is over 95%
- contracted recruitment targets reached 99% of the cases
Therapeutic areas:
pulmonology, cardiology, diabetology, lipidology, rheumatology, gastroenterology, infectology, gynecology, dermatology, neurology.